Loading...
The story of artesunate–mefloquine (ASMQ), innovative partnerships in drug development: case study
BACKGROUND: The Drugs for Neglected Diseases initiative (DNDi) is a not-for profit organization committed to providing affordable medicines and access to treatments in resource-poor settings. Traditionally drug development has happened “in house” within pharmaceutical companies, with research and de...
Na minha lista:
| Main Authors: | , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BioMed Central
2013
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3640935/ https://ncbi.nlm.nih.gov/pubmed/23433060 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1475-2875-12-68 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|